AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $572,000 | +14200.0% | 79,000 | +13066.7% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 600 | -43.7% | 0.00% | – |
| Q1 2019 | $2,000 | -80.0% | 1,066 | -73.2% | 0.00% | – |
| Q4 2018 | $10,000 | -41.2% | 3,981 | 0.0% | 0.00% | – |
| Q3 2018 | $17,000 | -43.3% | 3,981 | -20.1% | 0.00% | – |
| Q2 2018 | $30,000 | -16.7% | 4,981 | 0.0% | 0.00% | – |
| Q1 2018 | $36,000 | -12.2% | 4,981 | 0.0% | 0.00% | – |
| Q4 2017 | $41,000 | -2.4% | 4,981 | +25.1% | 0.00% | – |
| Q3 2017 | $42,000 | -4.5% | 3,981 | 0.0% | 0.00% | – |
| Q2 2017 | $44,000 | +12.8% | 3,981 | 0.0% | 0.00% | – |
| Q1 2017 | $39,000 | – | 3,981 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |